A Double-blind Study of KRN321 for the Treatment of Anemia in Cancer Patients

Phase 3 Completed 200 enrolled Kyowa Kirin, Inc.

RandomizedParallel-groupDouble-blindTreatment

Summary

To compare the effectiveness of KRN321 to placebo in the treatment of anemia in cancer patients receiving multi cycle platinum-containing chemotherapy

Timeline

Start: 2006-03
Primary completion: 2007-05
Completion: —

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Darbepoetin alfa	Protein / enzyme biologic	—	—

A Double-blind Study of KRN321 for the Treatment of Anemia in Cancer Patients

Summary

Timeline

Drugs

Indications